LEADER 01265nam--2200409---450-
001 990002663390203316
005 20050927105833.0
010   $a3-540-22568-4
035   $a000266339
035   $aUSA01000266339
035   $a(ALEPH)000266339USA01
035   $a000266339
100   $a20050927h2005----km-y0itaa50------ba
101 0 $aeng
102   $aDE
105   $ay|||z|||001yy
200 1 $aAnxiety and anxiolytic drugs$fcontributors A. Bilkei-Gorzo ... [et al.]$geditors Florian Holsboer and Andreas Ströhle
210   $aBerlin [etc.]$cSpringer$dcopyr. 2005
215   $aXII, 566 p.$d24 cm
225 2 $aHandbook of experimental pharmacology$v169
410  0$12001$aHandbook of experimental pharmacology$v169
454 1 $12001
461  1$1001------$12001
606 0 $aTranquillanti
676   $a615.7882
702  1$aBILKEI-GORZO,$bA.
702  1$aHOLSBOER,$bFlorian
702  1$aSTRÖHLE,$bAndreas
801  0$aIT$bsalbc$gISBD
912   $a990002663390203316
951   $a615.7882 ANX$b4010 Farm.$c615.7882$d00182641
959   $aBK
969   $aFAR
979   $aPECORARO$b90$c20050927$lUSA01$h1054
979   $aPECORARO$b90$c20050927$lUSA01$h1058
996   $aAnxiety and anxiolytic drugs$91004927
997   $aUNISA